Cargando…
Elucidation of the Mechanism of Action for Metal Based Anticancer Drugs by Mass Spectrometry-Based Quantitative Proteomics
The discovery of the anticancer activity of cisplatin and its clinical application has opened a new field for studying metal-coordinated anticancer drugs. Metal-based anticancer drugs, such as cisplatin, can be transported to cells after entering into the human body and form metal–DNA or metal–prote...
Autores principales: | Jia, Shuailong, Wang, Runjing, Wu, Kui, Jiang, Hongliang, Du, Zhifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384660/ https://www.ncbi.nlm.nih.gov/pubmed/30736320 http://dx.doi.org/10.3390/molecules24030581 |
Ejemplares similares
-
The Protein-Binding Behavior of Platinum Anticancer Drugs in Blood Revealed by Mass Spectrometry
por: Wang, Jingchen, et al.
Publicado: (2021) -
Mass Spectrometry-Based Label-Free Quantitative Proteomics
por: Zhu, Wenhong, et al.
Publicado: (2010) -
Mass Spectrometry-Based Approaches Toward Absolute Quantitative Proteomics
por: Kito, Keiji, et al.
Publicado: (2008) -
Proteomic Approaches in Understanding Action Mechanisms of
Metal-Based Anticancer Drugs
por: Wang, Ying, et al.
Publicado: (2008) -
Mass Spectrometry-Based Techniques to Elucidate the
Sugar Code
por: Grabarics, Márkó, et al.
Publicado: (2021)